Evidence map›Paper›PMID 18465404›Full record

ArticleExperimental lung research2008

Comparison of conditioning regimens for alveolar macrophage reconstitution and innate immune function post bone marrow transplant.

Leah L N Hubbard, Megan N Ballinger, Carol A Wilke, Bethany B Moore

Open access · greenAbstract readComparative Study
In one paragraph

Article in Experimental lung research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Review of Recent Developments in the Molecular Mechanisms of Bone Healing.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Prostaglandin EPharmacology & therapeutics · 2018
    Review
  18. Elevated prostaglandin EMucosal immunology · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Leah L N HubbardImmunology Graduate Program, University of Michigan, Ann Arbor, Michigan, USA.
Megan N Ballinger
Carol A Wilke
Bethany B Moore
University of Michigan–Ann Arbor · US

Funding

RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
PGE2 Regulation of Host Defense post-BMTR01AI065543 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOORE, BETHANY B. · 2007 to 2011
$1.9M
HSCT-induced changes that impair lung innate immunityR56AI065543 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MOORE, BETHANY B. · 2012 to 2012
$363k
NIAID NIH HHS R01 AI065543NIAID NIH HHS R56 AI065543NIAID NIH HHS T32 AI007413NIAID NIH HHS T32AI065543
6 · The paper itself

Abstract

The authors compared efficiency of alveolar macrophage (AM) reconstitution from donor bone marrow post transplant following 4 chemotherapy conditioning regimens and 2 total body irradiation (TBI) regimens. TBI regimens are more effective in inducing AM reconstitution from donor marrow. However, mice conditioned with 13 Gy split-dose TBI or a dual-chemotherapy regimen (25 mg/kg busulfan x 4 days plus cyclophosphamide 100 mg/kg x 2 days) both demonstrate significant AM repopulation from donor marrow. Additionally, both protocols resulted in impaired pulmonary host defense associated with overproduction of prostaglandin E(2) and I(2) by AMs and impaired AM phagocytosis post bone marrow transplant.

Indexed as

Transplantation ConditioningAnimalsBone Marrow TransplantationBronchoalveolar Lavage FluidBusulfanDinoprostoneDisease Models, AnimalEpoprostenolLungMacrophages, AlveolarMiceMice, Inbred C57BLMyeloablative AgonistsPhagocytosisPulmonary AlveoliSpecific Pathogen-Free OrganismsBusulfanDinoprostoneEpoprostenolMyeloablative Agonists

Identifiers

PMID18465404
PMCPMC3309395
OpenAlexW2069440395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.